| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Taub Institute for Research of Alzheimer’s Disease and the Aging Brain (Drs. Luchsinger, Tang, and Mayeux), Gertrude H. Sergievsky Center (Dr. Mayeux), and Departments of Biostatistics (Dr. Tang) and Epidemiology (Drs. Shea and Mayeux), Joseph P. Mailman School of Public Health, Columbia University, New York; and Division of General Medicine, Department of Medicine (Drs. Luchsinger and Shea), Department of Neurology (Dr. Mayeux), and Department of Psychiatry (Dr. Mayeux), Columbia University College of Physicians and Surgeons, New York, NY.
Address correspondence and reprint requests to Dr. Richard Mayeux, Gertrude H. Sergievsky Center, PH-19, 630 West 168th St., New York, NY 10032; e-mail: rpm2{at}columbia.edu
Objective: To explore the association between fasting insulin levels and dementia.
Methods: Fasting insulin levels were measured from frozen sera using solid-phase chemiluminescent enzyme immunoassay in a sample of elderly subjects chosen at random from a cohort of persons aged 65 years and older from northern Manhattan. Dementia was diagnosed using standard methods. Neuropsychiatric testing was available on all subjects at each follow-up interval.
Results: A total of 683 subjects without prevalent dementia were followed for 3,691 person-years and 149 persons developed dementia (137 Alzheimer disease [AD], 6 dementia associated with stroke, 6 other). The risk of AD doubled in the 39% of the sample with hyperinsulinemia (HR = 2.1; 95% CI: 1.5, 2.9) and was highest in people without diabetes. The HR relating presence of hyperinsulinemia or diabetes in 50% of our sample to AD was 2.2 (95% CI: 1.5, 3.1). The risk of AD attributable to the presence of hyperinsulinemia or diabetes was 39%. The HR of AD for the highest quartile of insulin compared to the lowest was 1.7 (95% CI: 1.0, 2.7; p for trend = 0.009). Hyperinsulinemia was also related to a significant decline in memory-related cognitive scores, but not to decline in other cognitive domains.
Conclusions: Hyperinsulinemia is associated with a higher risk of AD and decline in memory.
Received February 28, 2004. Accepted in final form June 4, 2004.
Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the October 12 issue to find the title link for this article.
Related Article
Neurology 2004 63: 1146-1147.
This article has been cited by other articles:
|
|
 |
|
  E. E. Devore, M. J. Stampfer, M. M.B. Breteler, B. Rosner, J. Hee Kang, O. Okereke, F. B. Hu, and F. Grodstein Dietary Fat Intake and Cognitive Decline in Women With Type 2 Diabetes Diabetes Care, April 1, 2009; 32(4): 635 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Fitzpatrick, L. H. Kuller, O. L. Lopez, P. Diehr, E. S. O'Meara, W. T. Longstreth Jr, and J. A. Luchsinger Midlife and Late-Life Obesity and the Risk of Dementia: Cardiovascular Health Study Arch Neurol, March 1, 2009; 66(3): 336 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Helzner, J. A. Luchsinger, N. Scarmeas, S. Cosentino, A. M. Brickman, M. M. Glymour, and Y. Stern Contribution of Vascular Risk Factors to the Progression in Alzheimer Disease Arch Neurol, March 1, 2009; 66(3): 343 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kuczynski, W. Jagust, H. C. Chui, and B. Reed An inverse association of cardiovascular risk and frontal lobe glucose metabolism Neurology, February 24, 2009; 72(8): 738 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Xu, C. Qiu, M. Gatz, N. L. Pedersen, B. Johansson, and L. Fratiglioni Mid- and Late-Life Diabetes in Relation to the Risk of Dementia: A Population-Based Twin Study Diabetes, January 1, 2009; 58(1): 71 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Llovera, M. de Tullio, L. G. Alonso, M. A. Leissring, S. B. Kaufman, A. E. Roher, G. de Prat Gay, L. Morelli, and E. M. Castano The Catalytic Domain of Insulin-degrading Enzyme Forms a Denaturant-resistant Complex with Amyloid {beta} Peptide: IMPLICATIONS FOR ALZHEIMER DISEASE PATHOGENESIS J. Biol. Chem., June 20, 2008; 283(25): 17039 - 17048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Rolandsson, A. Backestrom, S. Eriksson, G. Hallmans, and L.-G. Nilsson Increased Glucose Levels Are Associated With Episodic Memory in Nondiabetic Women Diabetes, February 1, 2008; 57(2): 440 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tsukuda, M. Mogi, J.-M. Li, J. Iwanami, L.-J. Min, A. Sakata, T. Fujita, M. Iwai, and M. Horiuchi Diabetes-Associated Cognitive Impairment Is Improved by a Calcium Channel Blocker, Nifedipine Hypertension, February 1, 2008; 51(2): 528 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-Q. Zhao, F. G. De Felice, S. Fernandez, H. Chen, M. P. Lambert, M. J. Quon, G. A. Krafft, and W. L. Klein Amyloid beta oligomers induce impairment of neuronal insulin receptors FASEB J, January 1, 2008; 22(1): 246 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tsukuda, M. Mogi, J.-M. Li, J. Iwanami, L.-J. Min, A. Sakata, T. Fujita, M. Iwai, and M. Horiuchi Amelioration of Cognitive Impairment in the Type-2 Diabetic Mouse by the Angiotensin II Type-1 Receptor Blocker Candesartan Hypertension, December 1, 2007; 50(6): 1099 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Cummings, R. Doody, and C. Clark Disease-modifying therapies for Alzheimer disease: Challenges to early intervention Neurology, October 16, 2007; 69(16): 1622 - 1634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Scarmeas, J. A. Luchsinger, R. Mayeux, and Y. Stern Mediterranean diet and Alzheimer disease mortality Neurology, September 11, 2007; 69(11): 1084 - 1093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Burns, J. E. Donnelly, H. S. Anderson, M. S. Mayo, L. Spencer-Gardner, G. Thomas, B. B. Cronk, Z. Haddad, D. Klima, D. Hansen, et al. Peripheral insulin and brain structure in early Alzheimer disease Neurology, September 11, 2007; 69(11): 1094 - 1104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Luchsinger, C. Reitz, B. Patel, M.-X. Tang, J. J. Manly, and R. Mayeux Relation of Diabetes to Mild Cognitive Impairment Arch Neurol, April 1, 2007; 64(4): 570 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Luchsinger, B. Patel, M.-X. Tang, N. Schupf, and R. Mayeux Measures of Adiposity and Dementia Risk in Elderly Persons Arch Neurol, March 1, 2007; 64(3): 392 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Xu, C. Qiu, B. Winblad, and L. Fratiglioni The Effect of Borderline Diabetes on the Risk of Dementia and Alzheimer's Disease Diabetes, January 1, 2007; 56(1): 211 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Young, A. G. Mainous III, and M. Carnemolla Hyperinsulinemia and Cognitive Decline in a Middle-Aged Cohort Diabetes Care, December 1, 2006; 29(12): 2688 - 2693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Scarmeas, Y. Stern, R. Mayeux, and J. A. Luchsinger Mediterranean Diet, Alzheimer Disease, and Vascular Mediation Arch Neurol, December 1, 2006; 63(12): 1709 - 1717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Akomolafe, A. Beiser, J. B. Meigs, R. Au, R. C. Green, L. A. Farrer, P. A. Wolf, and S. Seshadri Diabetes Mellitus and Risk of Developing Alzheimer Disease: Results From the Framingham Study Arch Neurol, November 1, 2006; 63(11): 1551 - 1555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Luchsinger A Work in Progress: The Metabolic Syndrome Sci. Aging Knowl. Environ., June 28, 2006; 2006(10): pe19 - pe19. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Sato, N. Shimogaito, X. Wu, S. Kikuchi, S.-i. Yamagishi, and M. Takeuchi Toxic Advanced Glycation End Products (TAGE) Theory in Alzheimer's Disease American Journal of Alzheimer's Disease and Other Dementias, May 1, 2006; 21(3): 197 - 208. [Abstract] [PDF]
|
|
|
|
|
|
C. M. Ryan, M. I. Freed, J. A. Rood, A. R. Cobitz, B. R. Waterhouse, and M. W.J. Strachan Improving Metabolic Control Leads to Better Working Memory in Adults With Type 2 Diabetes Diabetes Care, February 1, 2006; 29(2): 345 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Watson, M. A. Reger, L. D. Baker, M. J. McNeely, W. Y. Fujimoto, S. E. Kahn, E. J. Boyko, D. L. Leonetti, and S. Craft Effects of Exercise and Nutrition on Memory in Japanese Americans With Impaired Glucose Tolerance Diabetes Care, January 1, 2006; 29(1): 135 - 136. [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Manly, N. Schupf, M.-X. Tang, and Y. Stern Cognitive Decline and Literacy Among Ethnically Diverse Elders J Geriatr Psychiatry Neurol, December 1, 2005; 18(4): 213 - 217. [Abstract] [PDF]
|
|
|
|
|
|
S. Freude, L. Plum, J. Schnitker, U. Leeser, M. Udelhoven, W. Krone, J. C. Bruning, and M. Schubert Peripheral Hyperinsulinemia Promotes Tau Phosphorylation In Vivo Diabetes, December 1, 2005; 54(12): 3343 - 3348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Fishel, G. S. Watson, T. J. Montine, Q. Wang, P. S. Green, J. J. Kulstad, D. G. Cook, E. R. Peskind, L. D. Baker, D. Goldgaber, et al. Hyperinsulinemia Provokes Synchronous Increases in Central Inflammation and {beta}-Amyloid in Normal Adults Arch Neurol, October 1, 2005; 62(10): 1539 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Knopman, T. H. Mosley, D. J. Catellier, A. R. Sharrett, and for the Atherosclerosis Risk in Communities (ARIC) Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort Neurology, September 27, 2005; 65(6): 876 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Luchsinger, C. Reitz, L. S. Honig, M. X. Tang, S. Shea, and R. Mayeux Aggregation of vascular risk factors and risk of incident Alzheimer disease Neurology, August 23, 2005; 65(4): 545 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Okereke, S. E. Hankinson, F. B. Hu, and F. Grodstein Plasma C Peptide Level and Cognitive Function Among Older Women Without Diabetes Mellitus Arch Intern Med, July 25, 2005; 165(14): 1651 - 1656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ramasamy, S. J. Vannucci, S. S. D. Yan, K. Herold, S. F. Yan, and A. M. Schmidt Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation Glycobiology, July 1, 2005; 15(7): 16R - 28R. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Desai and G. T. Grossberg Diagnosis and treatment of Alzheimer's disease Neurology, June 28, 2005; 64(12_suppl_3): S34 - S39. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
